Sg Americas Securities, LLC Cytosorbents Corp Transaction History

Sg Americas Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$4.05 - $8.11 $56,878 - $113,896	-14,044 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$7.0 - $9.71 $98,308 - $136,367	14,044 New	14,044 $114,000
Q3 2020 Nov 09, 2020	SELL	$7.37 - $11.54 $138,386 - $216,686	-18,777 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$6.28 - $10.59 $50,321 - $84,857	8,013 Added 74.44%	18,777 $186,000
Q1 2020 Apr 30, 2020	BUY	$3.77 - $7.73 $40,580 - $83,205	10,764 New	10,764 $83,000

16.7M

15.4K

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $38.3M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.